Trametinib shows promise for children with relapsed or refractory JMML
Bottom Line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic...
Bottom Line: The MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with relapsed or refractory juvenile myelomonocytic...
Momentary shifts in mood, even those lasting just a matter of seconds, profoundly alter the brain’s response to pleasurable experiences...
A new partnership between education experts in Indonesia and the UK could transform lives by changing perceptions of disability. A...
Why do politicians lie and deny when they are caught up in political scandal?Credit: Craig Chandler/University Communication and Marketing/University of Nebraska-Lincoln...
The Science For the first time in history, scientists have measured radium’s bonding interactions with oxygen atoms in an organic...
A large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers after CAR-T cell therapy...
WASHINGTON – A new detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides...
DETROIT — Alice Walker, Ph.D., assistant professor of chemistry in the College of Liberal Arts and Sciences at Wayne State...
LAWRENCE — A partnership between scientists at the University of Kansas and collaborators in Europe, including war-torn Ukraine, will result...
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE 12, 2024 EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, JUNE...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2024 Scienmag - Science Magazine
© 2024 Scienmag - Science Magazine